Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Nov 18;192(2):281–291. doi: 10.1111/bjh.17211

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Fig 4 — (A) Survival of adult T‐cell leukaemia/lymphoma (ATL) patients who received allogeneic haematopoietic stem cell transplantation (HSCT), stratified according to CD28 gene alterations. (B) Survival from the day of allogeneic HSCT according to CD28 gene alterations. (C) Survival from the day of allogeneic HSCT of the 8 ATL patients with CD28 fusions and the 17 without CD28 gene alterations. (D) Survival from the day of allogeneic HSCT of the 11 ATL patients with CD28 copy number variation (CNV) and the 17 without CD28 gene alterations. (B–D) P < 0·05/3 (two‐sided) was considered statistically significant after correction. (E) Survival from the day of allogeneic HSCT in patients with acute or lymphoma subtypes stratified by CD28 gene alterations.